Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06415656 · ClinicalTrials.gov registry record · NA
VitalTraq for the Detection of CRS
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT06415656 is a NA study that has completed, run by Duke University. The registered enrollment target is 32 participants.
The verdict
NCT06415656, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate two vital sign monitoring devices, TempTraq and VitalTraq, in patients with hematologic malignancies undergoing therapy with Chimeric antigen receptor T-cell therapy (CAR-T) or Bispecific T-cell engagers (BiTE) products. TempTraq is an axillary patch that is worn on the skin and continuously monitors a patient's body temperature. VitalTraq is a smartphone application that utilizes remote photoplethysmography technology via a 30-second facial scan to estimate the patient's blood pressure (BP), heart rate (HR), heart rate variability (HRV), and respiratory rate. These remote vital sign monitoring devices have the potential to promote earlier detection and intervention of treatment-related toxicities, including cytokine release syndrome (CRS) and febrile neutropenia.
Interventions
- DEVICE TempTraq
- DEVICE VitalTraq
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2024-10-13 |
| Est. Completion | 2025-07-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06415656
The ClinicalTrials.gov registry entry for NCT06415656 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TempTraq is the first listed.
NCT06415656 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06415656 about?
NCT06415656 is a clinical study titled "VitalTraq for the Detection of CRS". The purpose of this study is to evaluate two vital sign monitoring devices, TempTraq and VitalTraq, in patients with hematologic malignancies undergoing therapy with Chimeric antigen receptor T-cell therapy (CAR-T) or Bispecific T-cell engagers (BiTE) products. TempTraq is an axillary patch that is ...
What is the current status of trial NCT06415656?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2024-10-13. Estimated completion is 2025-07-07.
What interventions are being tested in trial NCT06415656?
The interventions under investigation include: TempTraq (DEVICE), VitalTraq (DEVICE).
Who is sponsoring clinical trial NCT06415656?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.